DiaSorin
€74.90Change from previous close: +1.22%Absolute change: +€0.90
At a glance
- Revenue growth
- +0.81%
- 2025 vs 2024
- Net income growth
- −17.27%
- 2025 vs 2024
- Net margin
- 13.0%
- 2024: 15.9%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 1,195 | 1,185 | 1,148 | 1,361 | — |
| Cost of revenue | 422 | 404 | 407 | 461 | — |
| Gross profit | 773 | 782 | 741 | 901 | — |
| Selling, general and administrative | 364 | 376 | 368 | 365 | — |
| Research and development | 95.0 | 91.6 | 90.9 | 96.9 | — |
| Operating income | 270 | 265 | 238 | 375 | — |
| EBIT | 236 | 270 | 231 | 361 | — |
| EBITDA | 364 | 399 | 367 | 514 | — |
| Interest expense | 24.5 | 27.6 | 29.3 | 34.6 | — |
| Pre-tax income | 212 | 242 | 201 | 326 | — |
| Income tax | 61.6 | 55.4 | 42.7 | 85.8 | — |
| Net income | 156 | 188 | 160 | 241 | — |
| Net income to common shareholders | 156 | 188 | 160 | 241 | — |
| Basic EPS | 2.83 | 3.47 | 2.87 | 4.16 | — |
| Diluted EPS | 2.83 | 3.47 | 2.87 | 4.15 | — |
| Average shares (basic) | 53.0 | 53.9 | 55.7 | 57.8 | — |
| Average shares (diluted) | 53.0 | 53.9 | 55.7 | 58.0 | — |